ChartRow logo
Data provided bySource: Twelve Data
PeersDHRAIQVWATMTDUNH
Share this page

TMO financial statements

The full income statement, balance sheet, and cash-flow statement for Thermo Fisher Scientific Inc. (TMO), plus valuation ratios — straight from SEC filings. Switch between annual, quarterly, and trailing-twelve-month figures, pick how far back to look, and flip the time order. Every line has a trend sparkline.

Financial overview#

Revenue

5Y CAGR +6.7%10Y CAGR +10.1%YoY +9.1%
$47.4B TTM$12.1B Q3 '26
FY15FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25TTM
Q4 '16Q1 '17Q2 '17Q3 '17Q4 '17Q1 '18Q2 '18Q3 '18Q4 '18Q1 '19Q2 '19Q3 '19Q4 '19Q1 '20Q2 '20Q3 '20Q4 '20Q1 '21Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Gross profit

5Y CAGR +13.3%10Y CAGR +9.9%YoY +3.8%
— FY25— Q3 '26
FY15FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25
Q4 '16Q1 '17Q2 '17Q3 '17Q4 '17Q1 '18Q2 '18Q3 '18Q4 '18Q1 '19Q2 '19Q3 '19Q4 '19Q1 '20Q2 '20Q3 '20Q4 '20Q1 '21Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Operating income

5Y CAGR −0.1%10Y CAGR +12.7%YoY +16.6%
$8.5B TTM$2.3B Q3 '26
FY15FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25TTM
Q4 '16Q1 '17Q2 '17Q3 '17Q4 '17Q1 '18Q2 '18Q3 '18Q4 '18Q1 '19Q2 '19Q3 '19Q4 '19Q1 '20Q2 '20Q3 '20Q4 '20Q1 '21Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Net income

5Y CAGR +1.0%10Y CAGR +13.0%YoY +6.5%
$7.1B TTM$1.7B Q3 '26
FY15FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25TTM
Q4 '16Q1 '17Q2 '17Q3 '17Q4 '17Q1 '18Q2 '18Q3 '18Q4 '18Q1 '19Q2 '19Q3 '19Q4 '19Q1 '20Q2 '20Q3 '20Q4 '20Q1 '21Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

EPS (diluted)

5Y CAGR +2.1%10Y CAGR +13.7%YoY +8.7%
$18.95 TTM$4.64 Q3 '26
FY15FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25TTM
Q4 '16Q1 '17Q2 '17Q3 '17Q4 '17Q1 '18Q2 '18Q3 '18Q4 '18Q1 '19Q2 '19Q3 '19Q4 '19Q1 '20Q2 '20Q3 '20Q4 '20Q1 '21Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Operating cash flow

5Y CAGR −1.2%10Y CAGR +10.3%YoY +13.9%
$9.3B TTM$2.5B Q3 '26
FY15FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25TTM
Q4 '16Q1 '17Q2 '17Q3 '17Q4 '17Q1 '18Q2 '18Q3 '18Q4 '18Q1 '19Q2 '19Q3 '19Q4 '19Q1 '20Q2 '20Q3 '20Q4 '20Q1 '21Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Capital expenditure

5Y CAGR +0.7%10Y CAGR +13.7%YoY +8.2%
$1.7B TTM$437M Q3 '26
FY15FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25TTM
Q4 '16Q1 '17Q2 '17Q3 '17Q4 '17Q1 '18Q2 '18Q3 '18Q4 '18Q1 '19Q2 '19Q3 '19Q4 '19Q1 '20Q2 '20Q3 '20Q4 '20Q1 '21Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Free cash flow

5Y CAGR −1.6%10Y CAGR +9.6%YoY +15.1%
$7.6B TTM$2.1B Q3 '26
FY15FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25TTM
Q4 '16Q1 '17Q2 '17Q3 '17Q4 '17Q1 '18Q2 '18Q3 '18Q4 '18Q1 '19Q2 '19Q3 '19Q4 '19Q1 '20Q2 '20Q3 '20Q4 '20Q1 '21Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Shares (diluted)

5Y −5.3%10Y −6.0%YoY −1.9%
373.3M TTM371M Q3 '26
FY15FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25TTM
Q4 '16Q1 '17Q2 '17Q3 '17Q4 '17Q1 '18Q2 '18Q3 '18Q4 '18Q1 '19Q2 '19Q3 '19Q4 '19Q1 '20Q2 '20Q3 '20Q4 '20Q1 '21Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Dividend per share

5Y CAGR +14.3%10Y CAGR +11.1%YoY +9.3%
$1.84 TTM$0.47 Q3 '26
FY15FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25TTM
Q4 '16Q1 '17Q2 '17Q3 '17Q4 '17Q1 '18Q2 '18Q3 '18Q4 '18Q1 '19Q2 '19Q3 '19Q4 '19Q1 '20Q2 '20Q3 '20Q4 '20Q1 '21Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Every TMO chart on Trends →

Shares outstanding (point-in-time)

2024-09 382.5M2024-12 377.3M2025-03 377.5M2025-06 377.6M2025-09 375.7M2025-12 371.5M2026-03 371.6M2026-06 369.7M2026-09 370.5M-3.1% over 8 periods

SEC-filed end-of-period counts (cover pages and balance sheets, split-adjusted) — the series realized buyback yield is computed from. The weighted-average share lines in the statements below lag these by design: an average over the year sits near the midpoint of an ongoing buyback.

PeriodRangeOrderChangeFiguresAs-reported fiscal years.
Line itemTrendFY2025FY2024FY2023FY2022FY2021
Income Statementas ofDec 31 ’25as ofDec 31 ’24as ofDec 31 ’23as ofDec 31 ’22as ofDec 31 ’21
Revenue44.6B+3.9%42.9B+0.1%42.9B-4.6%44.9B+14.5%39.2B+21.7%
Research & development1.40B+0.5%1.39B+4.0%1.34B-9.1%1.47B+4.6%1.41B+19.1%
Selling, general & administrative8.73B+1.6%8.60B+1.8%8.45B-6.1%8.99B+12.3%8.01B+15.5%
Restructuring197M+103.1%97.0M-50.0%194M+185.3%68.0M+83.8%37.0M-27.5%
Amortization of intangibles1.73B-11.4%1.95B-16.5%2.34B-2.4%2.40B+36.0%1.76B+5.6%
Operating income7.75B+5.6%7.34B+7.0%6.86B-18.3%8.39B-16.3%10.0B+28.7%
Interest expense1.42B+2.1%1.39B+1.1%1.38B+89.4%726M+35.4%536M-3.1%
Interest & investment income993M-7.9%1.08B+22.6%879M+223.2%272M+532.6%43.0M-33.8%
Other non-operating income-12.0M-200.0%12.0M+118.5%-65.0M+37.5%-104M+85.0%-694M-813.2%
Equity-method income-41.0M+2.4%-42.0M+28.8%-59.0M+65.7%-172M-4200.0%-4.00M-33.3%
Pre-tax income7.31B+3.9%7.04B+11.7%6.30B-19.6%7.83B-11.4%8.84B+22.3%
Income tax547M-16.7%657M+131.3%284M-59.6%703M-36.6%1.11B+30.5%
6.70B+5.8%6.33B+5.7%6.00B-13.7%6.95B-10.0%7.72B+21.2%
Net income to non-controlling interest17.0M+466.7%3.00M+107.5%-40.0M-500.0%10.0M+233.3%3.00M+50.0%
Net income to common6.70B+5.8%6.33B+5.7%6.00B-13.7%6.95B-10.0%7.72B+21.2%
$17.74+7.3%$16.53+7.0%$15.45-12.4%$17.63-9.4%$19.46+21.9%
EPS (basic)$17.77+7.2%$16.58+6.8%$15.52-12.6%$17.75-9.5%$19.62+21.9%
Weighted-avg shares (basic)377M-1.3%382M-1.0%386M-1.5%392M-0.5%394M-0.5%
Weighted-avg shares (diluted)378M-1.3%383M-1.3%388M-1.5%394M-0.8%397M-0.5%
Dividends per share$1.72+10.3%$1.56+11.4%$1.40+16.7%$1.20+15.4%$1.04+18.2%
Balance Sheetas ofDec 31 ’25as ofDec 31 ’24as ofDec 31 ’23as ofDec 31 ’22as ofDec 31 ’21
28.7B+29.7%22.1B-10.0%24.6B-2.5%25.2B+25.4%20.1B-8.4%
Cash & equivalents9.85B+145.7%4.01B-50.4%8.08B-5.2%8.52B+90.4%4.48B-56.6%
Short-term investments253M-83.8%1.56B+51933.3%3.00M——
Accounts receivable8.90B+8.7%8.19B-0.4%8.22B+1.3%8.12B+1.7%7.98B+38.9%
Inventory5.42B+9.0%4.98B-2.2%5.09B-9.7%5.63B+11.5%5.05B+25.4%
Other current assets2.61B+33.0%1.96B+11.8%1.76B+6.9%1.64B+0.2%1.64B+45.0%
110B+13.4%97.3B-1.4%98.7B+1.6%97.2B+2.1%95.1B+37.8%
Property, plant & equipment10.6B+13.5%9.31B-1.5%9.45B+1.8%9.28B+11.4%8.33B+41.0%
Operating lease right-of-use1.45B-2.8%1.49B-4.3%1.56B-2.3%1.59B+4.0%1.53B+97.5%
Goodwill49.4B+7.7%45.9B+4.2%44.0B+6.9%41.2B-1.7%41.9B+61.0%
Intangible assets15.8B+2.0%15.5B-6.8%16.7B-4.4%17.4B-13.3%20.1B+58.6%
Other non-current assets5.87B+30.7%4.49B+12.3%4.00B-0.2%4.01B-13.6%4.64B+88.8%
15.2B+13.9%13.3B-4.9%14.0B-17.6%17.0B+26.6%13.4B+30.4%
Accounts payable3.62B+17.6%3.08B+7.2%2.87B-15.1%3.38B+17.9%2.87B+31.8%
Deferred revenue2.71B-5.0%2.85B+6.1%2.69B+3.4%2.60B-2.0%2.65B+108.9%
Short-term & current debt3.53B+59.6%2.21B-38.7%3.61B-35.3%5.58B+119.9%2.54B-3.5%
Current lease liability275M+5.4%261M-0.8%263M-3.3%272M+2.3%266M+44.6%
Other current liabilities3.33B+4.1%3.20B-1.4%3.25B-3.2%3.35B+13.7%2.95B+27.5%
56.8B+19.2%47.6B-8.2%51.9B-2.1%53.0B-2.1%54.1B+56.8%
Long-term debt35.9B+23.4%29.1B-7.2%31.3B+8.3%28.9B-10.6%32.3B+69.2%
Deferred revenue (non-current)1.18B+4.0%1.14B-24.1%1.50B+27.1%1.18B-4.8%1.24B+62.3%
Non-current lease liability1.20B-3.6%1.24B-0.4%1.24B-5.3%1.31B+9.1%1.20B+92.2%
Operating lease liability (total)1.47B-2.1%1.50B-0.4%1.51B-4.9%1.58B+7.9%1.47B+81.4%
Finance lease liability (total)213M+5.4%202M+6.3%190M-9.5%210M+5.0%200M+2757.1%
Deferred tax liabilities1.49B+17.7%1.27B-34.0%1.92B-32.5%2.85B-25.7%3.84B+113.9%
Other non-current liabilities4.27B+7.1%3.99B-14.1%4.64B+9.5%4.24B-6.7%4.54B+36.3%
53.4B+7.7%49.6B+6.1%46.7B+6.3%44.0B+7.8%40.8B+18.2%
Preferred stock0.000.000.000.000.00
Common stock445M+0.2%444M+0.5%442M+0.2%441M+0.5%439M+0.5%
Additional paid-in capital18.6B+3.3%18.0B+3.9%17.3B+3.2%16.7B+3.5%16.2B+3.8%
Retained earnings59.2B+11.4%53.1B+12.1%47.4B+13.0%41.9B+18.3%35.4B+26.0%
Treasury stock22.3B+16.0%19.2B+27.0%15.1B+25.9%12.0B+34.7%8.92B+30.9%
Accumulated other comprehensive income-2.45B+9.2%-2.70B+16.3%-3.22B-4.0%-3.10B-33.1%-2.33B+17.0%
Non-controlling interest7.00M+121.2%-33.0M-200.0%-11.0M-120.4%54.0M-12.9%62.0M+520.0%
Total equity incl. non-controlling53.4B+7.8%49.6B+6.1%46.7B+6.1%44.0B+7.8%40.9B+18.4%
Total liabilities & equity110B+13.4%97.3B-1.4%98.7B+1.6%97.2B+2.1%95.1B+37.8%
Common shares issued445M+0.3%444M+0.4%442M+0.3%441M+0.3%439M+0.5%
Common shares outstanding376M-1.2%381M-1.5%387M-1.0%391M-1.0%394M-0.6%
Shares outstanding (cover)371M-1.5%377M-1.1%381M-1.1%385M-1.5%391M-0.7%
Treasury shares68.9M+9.3%63.1M+13.5%55.5M+10.7%50.2M+12.2%44.7M+10.6%
Cash Flowas ofDec 31 ’25as ofDec 31 ’24as ofDec 31 ’23as ofDec 31 ’22as ofDec 31 ’21
7.82B-9.8%8.67B+3.1%8.41B-8.2%9.15B-1.7%9.31B+12.3%
Depreciation & amortization2.78B-10.6%3.11B-8.7%3.41B+0.7%3.38B+30.4%2.59B+11.5%
Intangible amortization1.73B-11.4%1.95B-16.5%2.34B-2.4%2.40B+36.0%1.76B+5.6%
Share-based compensation310M+3.0%301M+8.3%278M-9.4%307M+33.5%230M+17.3%
Deferred income taxes-639M+47.1%-1.21B+7.0%-1.30B-30.4%-997M-54.6%-645M-139.8%
Change in receivables426M+149.1%171M+297.7%43.0M-90.0%430M+110.8%204M-84.3%
Change in inventory74.0M+174.1%27.0M+104.5%-598M-172.5%825M-22.5%1.06B+109.6%
Change in payables421M+98.6%212M+142.4%-500M-177.2%648M+35.3%479M+711.9%
-4.05B+30.7%-5.84B-13.6%-5.14B-138.2%-2.16B+90.2%-21.9B-1352.5%
Capital expenditure1.52B+8.9%1.40B-5.3%1.48B-34.1%2.24B-11.1%2.52B+71.2%
Free cash flow6.29B-13.4%7.27B+4.9%6.93B+0.2%6.91B+1.8%6.79B-0.4%
Acquisitions4.04B+28.9%3.13B-14.4%3.66B+9284.6%39.0M-99.8%19.4B+50939.5%
Purchases of investments383M-88.7%3.40B+1532.7%208M+300.0%52.0M—
Sales/maturities of investments1.56B-11.6%1.77B+11700.0%15.0M-87.1%116M—
Proceeds from sale of PP&E44.0M-22.8%57.0M-34.5%87.0M+262.5%24.0M+20.0%20.0M+150.0%
Other investing activities-21.0M-162.5%-8.00M+75.8%-33.0M-65.0%-20.0M-147.6%42.0M+600.0%
1.80B+126.5%-6.79B-87.5%-3.62B-28.9%-2.81B-142.7%6.58B+586.2%
Long-term debt issued7.76B+544.4%1.20B-79.7%5.94B+86.1%3.19B-82.4%18.1B+423.6%
Long-term debt repaid2.41B-33.1%3.61B-37.6%5.78B+1441.9%375M-96.8%11.7B+1553.2%
Common stock issued0.000.000.000.000.00
Common stock repurchased3.00B-25.0%4.00B+33.3%3.00B+0.0%3.00B+50.0%2.00B+33.3%
Dividends paid636M+9.1%583M+11.5%523M+14.9%455M+15.2%395M+17.2%
Other financing activities90.0M-53.8%195M+248.2%56.0M+722.2%-9.00M-113.8%65.0M+41.3%
FX effect on cash
————194M+10.2%
Net change in cash5.84B+243.9%-4.06B-822.0%-440M-110.9%4.05B+169.2%-5.84B-173.9%
Interest paid1.61B+2.7%1.57B+13.4%1.39B+107.6%667M+20.2%555M+17.8%
Income taxes paid1.78B-3.2%1.83B+23.8%1.48B+20.1%1.23B-43.4%2.18B+64.8%
Valuation Ratiosas ofDec 31 ’25as ofDec 31 ’24as ofDec 31 ’23as ofDec 31 ’22as ofDec 31 ’21
Market cap218B+10.1%198B-3.4%205B-5.0%216B-17.9%263B+42.4%
P/E32.5×+4.0%31.3×-9.4%34.5×+12.4%30.7×-9.8%34.1×+17.6%
P/S4.9×+5.9%4.6×-2.2%4.7×-3.4%4.9×-27.1%6.7×+17.0%
P/B4.1×+2.2%4.0×-11.7%4.5×-8.8%5.0×-23.1%6.5×+20.5%
P/FCF34.6×+27.1%27.3×-13.0%31.3×-18.8%38.6×-0.5%38.8×+43.0%
Earnings yield3.1%-3.8%3.2%+10.4%2.9%-11.0%3.3%+10.9%2.9%-14.9%
FCF yield2.9%-21.3%3.7%+14.9%3.2%+23.1%2.6%+0.5%2.6%-30.1%
Dividend yield0.30%-1.0%0.30%+13.7%0.26%+21.0%0.22%+39.8%0.16%-17.5%
Source filing10-K10-K10-K10-K10-K
Fiscal yearCEOTotal, as reportedActually paidOther executives, average$100 in the stock$100 in peers
FY2025Mr. Casper$79.9M$116.1M$7.6M$126.05$156.63
FY2024—$30.4M$29.6M$10.9M$112.77$135.34
FY2023—$19M$9.2M$5.5M$114.74$128.02
FY2022—$28.2M−$4.7M$5.9M$118.73$121.83
FY2021—$21.2M$65.9M$8.2M$143.54$125.13
FY2020—$26.4M$79.7M$9M——

From the pay-versus-performance table of each proxy statement (DEF 14A), the newest that states the year. “Actually paid” values stock awards at the year’s closing price, so it falls when the stock does. A year two chief executives shared lists each one’s pay, as reported / actually paid, and the totals are both. $100 in the stock and in the peer group the proxy names are the newest proxy’s, from the start of its first year.

About this data

Source: TMO’s SEC filings (10-K / 10-Q). Annual columns are as-reported fiscal years; quarterly columns are as-reported fiscal quarters (Q4 derived as full-year minus the first three quarters where a company doesn’t file a standalone Q4); TTM (quarterly) rolls the trailing four quarters at every quarter end, TTM (yearly) samples that one year apart; balance-sheet rows show the period-end balance. Valuation ratios are sampled as of each period end. View all TMO filings on SEC EDGAR → Not investment advice.